CDP Capital Technology Ventures
24
20M
19
0.83
3
0.21
8
- Stages of investment
- Areas of investment
Summary
CDP Capital Technology Ventures appeared to be the VC, which was created in 1995. The main department of described VC is located in the Montru00e9al. The fund was located in North America if to be more exact in Canada.
Among the most popular portfolio startups of the fund, we may highlight Therion Biologics, Entrisphere, Ammasso. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Biotechnology, Biopharma.
The higher amount of exits for fund were in 2011. Comparing to the other companies, this CDP Capital Technology Ventures performs on 10 percentage points more the average number of lead investments. Considering the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2003. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the CDP Capital Technology Ventures, startups are often financed by Forward Ventures, Enterprise Partners, William Blair. The meaningful sponsors for the fund in investment in the same round are VantagePoint Capital Partners, Hambrecht & Quist Capital Management, 3i Group. In the next rounds fund is usually obtained by 3i Group, VantagePoint Capital Partners, Alta Partners.
The overall number of key employees were 3.
Investments analytics
Analytics
- Total investments
- 24
- Lead investments
- 3
- Exits
- 8
- Rounds per year
- 0.83
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (10)
- Medical (9)
- Pharmaceutical (8)
- Health Care (8)
- Biopharma (6) Show 24 more
- Investments by region
-
- United States (16)
- Canada (6)
- United Kingdom (2)
- Peak activity year
- 2003
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 46M
- Group Appearance index
- 0.92
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.67
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| CymaBay Therapeutics | 29 Aug 2003 | Biotechnology, Pharmaceutical, Biopharma | Early Stage Venture | 27M | United States, California, Hayward |
| TransMedics | 27 Jan 2004 | Health Care, Medical Device, Medical | Early Stage Venture | 27M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.